Covid Science: Virus leaves antibodies that may attack healthy tissues | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
The Business Standard

Tuesday
December 05, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
TUESDAY, DECEMBER 05, 2023
Covid Science: Virus leaves antibodies that may attack healthy tissues

Coronavirus chronicle

Reuters
04 January, 2022, 06:20 pm
Last modified: 04 January, 2022, 06:29 pm

Related News

  • 98% people developed antibodies after 2nd Covid jab
  • New Covid pills are needed as much as ever
  • Coronavirus can destroy the placenta and lead to stillbirths
  • Pandemic may affect infants' brain development; coronavirus can trigger kidney scarring
  • India's Covid-19 cases set for new highs as Omicron spreads

Covid Science: Virus leaves antibodies that may attack healthy tissues

Among 177 healthcare workers who had recovered from confirmed coronavirus infections contracted before the availability of vaccines, all had persistent autoantibodies, including ones that can cause chronic inflammation and injury of the joints, skin and nervous system

Reuters
04 January, 2022, 06:20 pm
Last modified: 04 January, 2022, 06:29 pm
People line up for a Covid-19 test at a hospital, during the coronavirus disease (Covid-19) pandemic in the Bronx borough of New York City, New York, US, 3 January, 2022. PHOTO: REUTERS/Carlo Allegri
People line up for a Covid-19 test at a hospital, during the coronavirus disease (Covid-19) pandemic in the Bronx borough of New York City, New York, US, 3 January, 2022. PHOTO: REUTERS/Carlo Allegri

The following is a summary of some recent studies on Covid-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review.

Coronavirus leaves survivors with self-attacking antibodies

Months after recovering from SARS-CoV-2 infection, survivors have elevated levels of antibodies that can mistakenly attack their own organs and tissues, even if they had not been severely ill, according to new findings.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

Among 177 healthcare workers who had recovered from confirmed coronavirus infections contracted before the availability of vaccines, all had persistent autoantibodies, including ones that can cause chronic inflammation and injury of the joints, skin and nervous system. "We would not normally expect to see such a diverse array of autoantibodies elevated in these individuals or stay elevated for as long six months after full clinical recovery," said Susan Cheng of the Cedars-Sinai Smidt Heart Institute in Los Angeles. Patterns of elevated autoantibodies varied between men and women, the researchers reported on Thursday in the Journal of Translational Medicine.

"We don't yet know how much longer, beyond six months, the antibodies will stay elevated and/or lead to any important clinical symptoms," Cheng said. "It will be essential to monitor individuals moving forward." Her team is investigating whether autoantibody elevations are linked with persistent symptoms in people with long Covid and planning to study autoantibody levels after infections with newer variants of the virus.

B cells' effects weakened but not defeated by Omicron

The effects of antibodies produced by the immune system's "memory B cells" against the Omicron variant of the coronavirus, while weakened, could still be significant, researchers believe.

Once the body learns to recognize SARS-CoV-2, either after infection or vaccination, B cells generate fresh antibodies against the virus if there are not already enough antibodies circulating in the blood that can neutralize it. In a study reported on bioRxiv ahead of peer review, researchers analyzed the strength of more than 300 antibodies produced by memory B cells obtained from vaccinated volunteers, including some who had a prior SARS-CoV-2 infection.

"Omicron seemed to evade a very large share of the memory B cells pool," researchers said, adding that it "seems to still be efficiently recognized by 30% of total antibodies and close to 10% of all potent neutralizing antibodies," said Matthieu Mahevas and Pascal Chappert of Universite de Paris in a joint email. Memory B cells' robust ability to proliferate and produce antibodies might compensate "in less than two days" for those antibodies' reduced effectiveness, they speculate.

In combination with other immune system components, particularly T cells, the effects of B cells likely help to explain why most vaccinated individuals who become infected do not become sick enough to require hospitalization, they said.

Virus variants' activity in cells makes them more effective

Along with spike mutations that help the coronavirus break into cells, mutations that change how the virus behaves inside the cells are a big factor in why some variants have been more transmissible, researchers have discovered.

The findings, published in Nature, show that scientists "have to start looking at mutations outside the spike," which has so far been the main focus of vaccines and antibody drugs, said Nevan Krogan of the University of California, San Francisco. Studying the Alpha variant, his team found a mutation at a non-spike site that causes infected cells to ramp up their production of a protein called Orf9B. Orf9b in turn disables a protein called TOM70 that cells use to send signals to the immune system. With higher levels of Orf9B disabling TOM70, the immune system does not respond as well and the virus can better evade detection, the researchers said.

Referring to the increase in Orf9B, Krogan said, "It's rare that mutations 'turn up' a protein. It's a very sneaky thing for this virus to do." The same mutation was identified on Delta, "and sure enough, almost the same mutation is on Omicron," he said, which suggests they may have similar effects on the immune system. The new information could spur development of drugs that target the interaction of Orf9b and TOM70.

Top News / World+Biz

Coronavirus Antibodies / Coronavirus impact / Covid-19 Antibody / Covid-19 impacts

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Illustration: TBS
    Finance minister's wealth drops after giving money away to wife, daughter, grandchildren
  • Photo: Collected
    Bangladesh to ask WB for $250m more in budget support
  • This file photo from December 2019 shows a rider driving his motorcycle through cold wind and fog. A scene not yet visible this year. Photo: Mumit M
    Why is 'winter not coming' yet

MOST VIEWED

  • LPG cylinders. Photo: Courtesy
    12kg LPG cylinder price up Tk23
  • For the first time, Bangladesh seeks foreign loans to support Rohingyas
    For the first time, Bangladesh seeks foreign loans to support Rohingyas
  • Photo: Collected
    Indonesia volcano erupts, spews ash 3 km into sky
  • External trade through Islamic banks in decline
    External trade through Islamic banks in decline
  • Halal products export receives boost with new policy, but more is required
    Halal products export receives boost with new policy, but more is required
  • Exports up 27% in Nov as peak festival sales begin in West
    Exports up 27% in Nov as peak festival sales begin in West

Related News

  • 98% people developed antibodies after 2nd Covid jab
  • New Covid pills are needed as much as ever
  • Coronavirus can destroy the placenta and lead to stillbirths
  • Pandemic may affect infants' brain development; coronavirus can trigger kidney scarring
  • India's Covid-19 cases set for new highs as Omicron spreads

Features

Ghulam Ali

Ghulam Ali: Voice that makes ghazals bloom

1h | Features
Exploring door designs: Redefining spaces and experiences

Exploring door designs: Redefining spaces and experiences

3h | Habitat
A brain drain query: Why do they leave?

A brain drain query: Why do they leave?

8h | Panorama
The school has been flooding since June 2007 and the water level is rising every year. PHOTO: COURTESY

Will Dubai pay heed to the suffering of Sultan Al Nahyan School students in Bangladesh?

8h | Panorama

More Videos from TBS

Labour Bill to be reintroduced in 12th Parliament

Labour Bill to be reintroduced in 12th Parliament

2h | TBS Economy
November export earnings up 27 percent over previous month: EPB

November export earnings up 27 percent over previous month: EPB

4h | TBS Economy
Amitabh Bachchan's assets worth Rs 3,700 crore divided

Amitabh Bachchan's assets worth Rs 3,700 crore divided

3h | TBS Entertainment
External trade through Islamic banks in decline

External trade through Islamic banks in decline

5h | TBS Economy
EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]